1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine

C141H227N15O6S — CID 158469819

IUPAC1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine
SMILESCC(C)(C)c1ccc(CN2CCNCC2)cc1.CC(C)(C)c1ccc(CN2CCOCC2)cc1.CC(C)(C)c1ccc(NC2CCN(S(C)(=O)=O)CC2)cc1.CC(C)(C)c1ccc(NC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCN(CCN)CC2)c1.CC(C)N1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.CN(c1ccc(C(C)(C)C)cc1)C1CCOC1.CN1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.COCCCOc1ccc(C(C)(C)C)cc1
InChIInChI=1S/C18H30N2.C17H29N3.C16H26N2O2S.C16H26N2.2C15H24N2.2C15H23NO.C14H22O2/c1-14(2)20-12-10-17(11-13-20)19-16-8-6-15(7-9-16)18(3,4)5;1-17(2,3)16-6-4-5-15(13-16)14-20-11-9-19(8-7-18)10-12-20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(12-10-15)21(4,19)20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(4)12-10-15;1-15(2,3)14-6-4-13(5-7-14)12-17-10-8-16-9-11-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)12-5-7-13(8-6-12)16(4)14-9-10-17-11-14;1-15(2,3)14-6-4-13(5-7-14)12-16-8-10-17-11-9-16;1-14(2,3)12-6-8-13(9-7-12)16-11-5-10-15-4/h6-9,14,17,19H,10-13H2,1-5H3;4-6,13H,7-12,14,18H2,1-3H3;5-8,15,17H,9-12H2,1-4H3;5-8,15,17H,9-12H2,1-4H3;4-7,16H,8-12H2,1-3H3;4-7,14,16-17H,8-11H2,1-3H3;5-8,14H,9-11H2,1-4H3;4-7H,8-12H2,1-3H3;6-9H,5,10-11H2,1-4H3
InChIKeyHGFHCOLXGWKKOU-UHFFFAOYSA-N
MW2260.53 g/mol
LogP27.60
Rot. Bonds25

About 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine

1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine (PubChem CID 158469819) has the molecular formula C141H227N15O6S and a molecular weight of 2260.53 g/mol. Its IUPAC name is 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine.

Molecular Properties

Compound Name1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine
PubChem CID158469819
Molecular FormulaC141H227N15O6S
Molecular Weight2260.53 g/mol
Exact Mass2258.76
IUPAC Name1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine
SMILESCC(C)(C)c1ccc(CN2CCNCC2)cc1.CC(C)(C)c1ccc(CN2CCOCC2)cc1.CC(C)(C)c1ccc(NC2CCN(S(C)(=O)=O)CC2)cc1.CC(C)(C)c1ccc(NC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCN(CCN)CC2)c1.CC(C)N1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.CN(c1ccc(C(C)(C)C)cc1)C1CCOC1.CN1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.COCCCOc1ccc(C(C)(C)C)cc1
InChIInChI=1S/C18H30N2.C17H29N3.C16H26N2O2S.C16H26N2.2C15H24N2.2C15H23NO.C14H22O2/c1-14(2)20-12-10-17(11-13-20)19-16-8-6-15(7-9-16)18(3,4)5;1-17(2,3)16-6-4-5-15(13-16)14-20-11-9-19(8-7-18)10-12-20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(12-10-15)21(4,19)20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(4)12-10-15;1-15(2,3)14-6-4-13(5-7-14)12-17-10-8-16-9-11-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)12-5-7-13(8-6-12)16(4)14-9-10-17-11-14;1-15(2,3)14-6-4-13(5-7-14)12-16-8-10-17-11-9-16;1-14(2,3)12-6-8-13(9-7-12)16-11-5-10-15-4/h6-9,14,17,19H,10-13H2,1-5H3;4-6,13H,7-12,14,18H2,1-3H3;5-8,15,17H,9-12H2,1-4H3;5-8,15,17H,9-12H2,1-4H3;4-7,16H,8-12H2,1-3H3;4-7,14,16-17H,8-11H2,1-3H3;5-8,14H,9-11H2,1-4H3;4-7H,8-12H2,1-3H3;6-9H,5,10-11H2,1-4H3
InChIKeyHGFHCOLXGWKKOU-UHFFFAOYSA-N
XLogP27.60
TPSA195.18 Ų
H-Bond Donors7
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms163
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002260.53
LogP ≤ 527.60
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine?
The IUPAC name of 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine (CID 158469819) is 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine.
What is the SMILES notation for 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine?
The canonical SMILES for 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine is CC(C)(C)c1ccc(CN2CCNCC2)cc1.CC(C)(C)c1ccc(CN2CCOCC2)cc1.CC(C)(C)c1ccc(NC2CCN(S(C)(=O)=O)CC2)cc1.CC(C)(C)c1ccc(NC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCN(CCN)CC2)c1.CC(C)N1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.CN(c1ccc(C(C)(C)C)cc1)C1CCOC1.CN1CCC(Nc2ccc(C(C)(C)C)cc2)CC1.COCCCOc1ccc(C(C)(C)C)cc1.
What is the InChIKey of 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine?
The InChIKey is HGFHCOLXGWKKOU-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H30N2.C17H29N3.C16H26N2O2S.C16H26N2.2C15H24N2.2C15H23NO.C14H22O2/c1-14(2)20-12-10-17(11-13-20)19-16-8-6-15(7-9-16)18(3,4)5;1-17(2,3)16-6-4-5-15(13-16)14-20-11-9-19(8-7-18)10-12-20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(12-10-15)21(4,19)20;1-16(2,3)13-5-7-14(8-6-13)17-15-9-11-18(4)12-10-15;1-15(2,3)14-6-4-13(5-7-14)12-17-10-8-16-9-11-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)12-5-7-13(8-6-12)16(4)14-9-10-17-11-14;1-15(2,3)14-6-4-13(5-7-14)12-16-8-10-17-11-9-16;1-14(2,3)12-6-8-13(9-7-12)16-11-5-10-15-4/h6-9,14,17,19H,10-13H2,1-5H3;4-6,13H,7-12,14,18H2,1-3H3;5-8,15,17H,9-12H2,1-4H3;5-8,15,17H,9-12H2,1-4H3;4-7,16H,8-12H2,1-3H3;4-7,14,16-17H,8-11H2,1-3H3;5-8,14H,9-11H2,1-4H3;4-7H,8-12H2,1-3H3;6-9H,5,10-11H2,1-4H3.
What are the key properties of 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine?
1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine has a molecular weight of 2260.53 g/mol, XLogP of 27.60, 25 rotatable bonds, 7 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-tert-butyl-4-(3-methoxypropoxy)benzene;4-[(4-tert-butylphenyl)methyl]morpholine;N-(4-tert-butylphenyl)-N-methyloxolan-3-amine;1-[(4-tert-butylphenyl)methyl]piperazine;2-[4-[(3-tert-butylphenyl)methyl]piperazin-1-yl]ethanamine;N-(4-tert-butylphenyl)-1-methylpiperidin-4-amine;N-(4-tert-butylphenyl)-1-methylsulfonylpiperidin-4-amine;N-(4-tert-butylphenyl)piperidin-4-amine;N-(4-tert-butylphenyl)-1-propan-2-ylpiperidin-4-amine is sourced from PubChem (CID 158469819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).